Medical Condition News

RSS

"Millions Suffer, Few Understand" encourages patients to talk openly about IC/BPS

This September, patients around the world will unite to share their personal stories and struggles with interstitial cystitis / bladder pain syndrome (IC/BPS). The 2013 theme, "Millions Suffer, Few Understand" encourages patients and providers to talk openly about this common yet often misunderstood pelvic pain condition.

5 Sep 2013

World's leading scientists to explore health benefits of Hydrogen Sulfide at conference

A gas associated with the smell of rotten of eggs is now being proven to have widespread health benefits. Hydrogen Sulfide is widely known as a poisonous and corrosive substance, but now a mounting body of evidence suggests it could be used in a wide range of treatments for some of the biggest health problems of our time. A conference hosted by the University of Exeter will bring together world-leading scientists to explore the emerging possibilities.

5 Sep 2013

Understanding single-sided deafness

Single-sided deafness, or being deaf in one ear, isn't exactly the poster-child for disabilities. Rather, it's an overlooked condition that is often misunderstood by the public. There is no way to see SSD, also called profound unilateral hearing loss, so those who suffer from it are often misperceived as "rude" or "unintelligent" when they don't understand or quickly respond to others. That's just one of the many hidden struggles associated with this condition.

5 Sep 2013

Head and neck cancer patients receiving radiation benefit from swallowing exercises

A study at UCLA's Jonsson Comprehensive Cancer Center has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to need a feeding tube or suffer unwanted side effects such as worsening of diet or narrowing of the throat passage if they performed a set of prescribed swallowing exercises - called a "swallow preservation protocol" - during therapy.

5 Sep 2013

ESMO recognises oncologists with prestigious awards

The European Society for Medical Oncology, the leading pan-European organisation representing medical oncology professionals, announced today the recipients of the annual society's prestigious awards, recognising excellence in oncology.

5 Sep 2013

Study reveals large gap between detection, control of hypertension across all countries

In a study that included more than 140,000 participants from17 countries of varying income levels, researchers found a large gap between both detection and control of hypertension across all countries studied, with just over half of participants with hypertension aware of their diagnosis, and about one-third of those being treated for hypertension successfully controlling their blood pressure, according to a study in the September 4 issue of JAMA.

5 Sep 2013

World Bank Group, IHME reports to help policymakers tackle health issues facing countries

In the Middle East and North Africa, heart disease, stroke, and diabetes are causing a massive amount of premature death and disability. People in Latin America and the Caribbean are living longer on the whole, yet they face increasing threats from chronic diseases. Mortality has declined in many South Asian countries, yet the number of deaths by non-communicable diseases and self-harm has skyrocketed since 1990.

5 Sep 2013

Obesity gene testing may help reduce self-blame

Obesity gene testing does not put people off weight loss and may help to reduce self-blame, according to a new study by researchers from the Health Behaviour Research Centre at UCL (University College London).

5 Sep 2013

Nanofibrous nerve conduits for repair of long sciatic nerve defects

Autografts or allografts are commonly used in the repair of damaged peripheral nerves. However, similar problems have been encountered in allografting or xenografting. Previous studies concerning artificial neural tubes to repair nerve defects mainly focus on peripheral nerve defects less than 30 mm.

5 Sep 2013

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

ThromboGenics NV, a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that it has entered into a collaboration and license agreement with Bicycle Therapeutics to develop and commercialize novel drugs inhibiting a specific target for the treatment of ophthalmic diseases, such as diabetic macular edema.

5 Sep 2013

Elan enrolls first patient dosing in phase 2a study of ELND005 in Down syndrome

Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome. Study ELND005-DS201 will evaluate the safety and pharmacokinetics of 2 doses of ELND005 and placebo in young adults with Down syndrome without dementia, and will also include select cognitive and behavioural measures.

5 Sep 2013

FIBRO-TARGETS project aims to identify mechanisms involved in MIF, define therapeutic approaches

Unravelling the mechanisms of cardiac fibrosis will lead to the discovery of therapeutic target candidates for various cardiac diseases. FIBRO-TARGETS brings together eleven European expert teams from six different countries both from public research institutes and European biotechs.

5 Sep 2013

New systematic review analyzes patterns of vitamin D status worldwide

A new systematic review published in the British Journal of Nutrition, is one of the first to focus on patterns of vitamin D status worldwide and in key population subgroups, using continuous values for 25(OH)D to improve comparisons.

5 Sep 2013

Natural compound in broccoli helps reduce risk for skin cancer

With skin cancer emerging as one of the world's most prevalent forms of cancer, researchers are using every tool at their disposal to fight this disease. The tool of choice for Sally Dickinson, PhD? Broccoli.

5 Sep 2013

Heart researchers to establish stronger cardiovascular network in Chicago area

Heart research in Chicago will enter a new era Sept. 20 when top researchers from all of Chicago's major academic medical centers meet at the American Heart Association's 2013 Chicago Research Network Symposium.

5 Sep 2013

Blood levels of cystatin C strengthen association between kidney function and risks of renal disease

A new, international study from the Chronic Kidney Disease Prognosis Consortium found that use of blood levels of cystatin C to estimate kidney function—alone or in combination with creatinine—strengthens the association between kidney function and risks of death and end-stage renal disease.

5 Sep 2013

TSRI scientists discover isoform of angiomotin protein responsible for tumorigenesis

A team led by scientists from The Scripps Research Institute (TSRI) have shown that a protein once thought to inhibit the growth of tumors is instead required for initial tumor growth. The findings could point to a new approach to cancer treatment.

5 Sep 2013

Research indicates that spouses tend to have similar levels of planning for retirement

As Baby Boomers begin entering retirement, some may find themselves unprepared for the transition. New research from the University of Missouri indicates that spouses tend to have similar levels of planning for retirement. This planning can lead to more success and less stress when they leave the workforce.

5 Sep 2013

Study: People with cataract-related vision loss who undergo cataract surgery live longer

People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.

5 Sep 2013

Secondary prevention drugs produce decline in stroke risk after AMI in diabetic patients

The findings were presented at the ESC Congress today by Ms Stina Jakobsson from Sweden. They reveal that reperfusion therapy and secondary prevention drugs produced the decline and brought stroke risk after AMI closer to that of non-diabetics.

5 Sep 2013

Medical Condition News

"Millions Suffer, Few Understand" encourages patients to talk openly about IC/BPS

World's leading scientists to explore health benefits of Hydrogen Sulfide at conference

Understanding single-sided deafness

Head and neck cancer patients receiving radiation benefit from swallowing exercises

ESMO recognises oncologists with prestigious awards

Study reveals large gap between detection, control of hypertension across all countries

World Bank Group, IHME reports to help policymakers tackle health issues facing countries

Obesity gene testing may help reduce self-blame

Nanofibrous nerve conduits for repair of long sciatic nerve defects

ThromboGenics, Bicycle to develop and commercialize novel drugs for ophthalmic diseases

Elan enrolls first patient dosing in phase 2a study of ELND005 in Down syndrome

FIBRO-TARGETS project aims to identify mechanisms involved in MIF, define therapeutic approaches

New systematic review analyzes patterns of vitamin D status worldwide

Natural compound in broccoli helps reduce risk for skin cancer

Heart researchers to establish stronger cardiovascular network in Chicago area

Blood levels of cystatin C strengthen association between kidney function and risks of renal disease

TSRI scientists discover isoform of angiomotin protein responsible for tumorigenesis

Research indicates that spouses tend to have similar levels of planning for retirement

Study: People with cataract-related vision loss who undergo cataract surgery live longer

Secondary prevention drugs produce decline in stroke risk after AMI in diabetic patients

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News